Rheumatology services are limited or non-existent in many parts of sub-Saharan Africa. Basic diagnostic tests, biological agents, and treatments are either unavailable or not affordable for the majority of people living in that area.
This shortage results in patients not having the benefit of early diagnosis and management of relatively cheap and cost-effective therapies. Instead, they present at advanced stages of disease with otherwise preventable morbidity.
Host Michael Greenberg chats with Dr. Michele Meltzer, Associate Professor at Jefferson University Hospitals in Philadelphia and President of the non-profit organization, Rheumatology for All, about providing medical training and care for countries with limited or non-existent rheumatology services.